We observed lost BAX protein expression in ALL cells with acquired but not intrinsic VEN-resistance, in line with a report on pathogenic BAX mutations in acute myeloid leukemia cases with acquired resistance after VEN therapy but not in primary VEN-refractory patients [26]. The gene discussed is BAX; the disease is acute lymphoblastic leukemia.